Gladstone Institutional Advisory’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
3,174
+721
+29% +$271K 0.04% 385
2026
Q1
$691K Sell
2,453
-153
-6% -$44.4K 0.03% 460
2025
Q4
$770K Sell
2,606
-34
-1% -$10.2K 0.03% 418
2025
Q3
$650K Sell
2,640
-2,098
-44% -$423K 0.03% 454
2025
Q2
$740K Buy
4,738
+335
+8% +$35.6K 0.03% 406
2025
Q1
$347K Sell
4,403
-4,644
-51% -$493K 0.02% 547
2024
Q4
$835K Sell
9,047
-132
-1% -$10.3K 0.04% 360
2024
Q3
$469K Buy
9,179
+2,348
+34% +$121K 0.02% 464
2024
Q2
$392K Buy
+6,831
New +$345K 0.02% 478

Other funds holding CLS

Gladstone Institutional Advisory's CLS Position: Q2 2026 in Review

Gladstone Institutional Advisory increased its Celestica (CLS) stake by 29% in Q2 2026, buying an estimated $271K and bringing the position to 3,174 shares worth $1.16M. The position accounts for 0.04% of the portfolio, ranked #385.

Gladstone Institutional Advisory first reported a position in CLS in Q2 2024 and has held it in 9 quarters since. 233 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Gladstone Institutional Advisory held 3,174 shares of Celestica worth $1.16M as of Q2 2026.
  • Gladstone Institutional Advisory bought 721 Celestica shares in Q2 2026, an estimated $271K.
  • Celestica made up 0.04% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #385 holding.
  • Gladstone Institutional Advisory first reported a position in Celestica in Q2 2024 and has held it in 9 quarters since.
  • 233 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.